Ebglyss for Atopic Dermatitis One of the latest treatments for atopic dermatitis is Ebglyss (lebrikizumab), a targeted biologic therapy for moderate-to-severe atopic dermatitis. Understanding Atopic Dermatitis Atopic dermatitis (AD), commonly known as eczema, is a chronic inflammatory skin condition characterized by intense itching, redness, and skin barrier disruption. It affects millions of individuals worldwide and… Read More
Managing Vascular Occlusion
How to Handle Vascular Occlusion After Filler Injection Vascular occlusion is a rare but serious complication that can occur after dermal filler injections. It is caused by unintentional injection into or near an artery, resulting in restricted blood flow, leading to tissue ischemia and even necrosis. This serious complication can happen even to experienced injectors.… Read More
Shared Medical Office Space – A New Way To Practice Medicine
Doctors are finding new ways to practice medicine without the fixed overhead. Shared medical space is the wave of the future, where doctors rent the space they need when they need it. Other services are also often available, such as shared reception, billing, EMR software, supplies purchasing and more. Doctors can just show up and… Read More
Filler for Nasolabial Folds
Nasolabial folds, also known as melolabial folds, are the lines that run from the sides of the nose to the corners of the mouth. These natural creases can deepen with age, causing a tired or aged appearance. While aging is the primary cause, factors such as genetics, sun exposure, and smoking can accelerate the formation… Read More
Telemedicine Dermatology in New Jersey and New York
SOMA Skin & Laser offers Telemedicine dermatology services. you can be seen by your dermatologist with phone, video, or text. Start a telemedicine call with Dr. Ehrenreich Enter waiting room Telemedicine by Doxy.me
Skyrizi for Psoriasis
Skyrizi (risankizumab-rzaa) joins the ever-growing ranks of biologics for the treatment of psoriasis. Skyrizi is new IL-23 inhibitor, which binds to the p19 subunit, joining Tremfya and Ilumya, and Stelara (which binds to the p40 subunit). It is approved for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy of phototherapy. Skyrizi has… Read More
Risks For Basal Cell Carcinoma Skin Cancer
Basal cell carcinoma (BCC) is the most common cancer worldwide. In the United States, the lifetime risk of developing BCC is estimated to be around 20%, and 30% in whites. It is the most common skin cancer seen by most dermatologists. Although many things in life are out of our control, there are some risk… Read More
